MGC Pharmaceuticals Ltd. has signed an exclusive distribution agreement with Sciensus Rare, a part of UK health care group, Sciensus, for the distribution of CannEpil® and CogniCann® in key European territories and the UK. The agreement is for the distribution in key European territories and the UK for CannEpil®, used to treat Drug Resistant Epilepsy,…
eTurboNews izindatshana ezababhalisi kuphela. Ukubhalisa kuyinto MAHHALA.
Ababhalisile bangena lapha Chofoza lapha ukuze ubhalise MAHHALA
Ababhalisile bangena lapha Chofoza lapha ukuze ubhalise MAHHALA
LOKHO ONGAKUTHATHE KULESI SIHLOKO:
- has signed an exclusive distribution agreement with Sciensus Rare, a part of UK health care group, Sciensus, for the distribution of CannEpil® and CogniCann® in key European territories and the UK.
- The agreement is for the distribution in key European territories and the UK for CannEpil®, used to treat Drug Resistant Epilepsy,….
- eTurboNews izindatshana ezababhalisi kuphela.
